Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-09-28FDA Approved: QUETIAPINE EXTENDED-RELEASE — Original Application (AlignScience Pharma Inc.)
FDA approved AlignScience Pharma Inc.'s generic extended-release quetiapine tablets (ANDA 209497). The approval enables a generic version of…
-
FDA approval · 2018-09-10FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved chlorpromazine hydrochloride under an original application from Amneal Pharmaceuticals; approved indications include schizophre…
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine [Phase 4]
Phase 4 trial investigating the effect of metformin on obesity and metabolic disturbance in patients taking clozapine for schizophrenia; stu…
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Minocycline Augmentation to Clozapine [Phase 4]
Phase 4 clinical trial updating minocycline augmentation of clozapine in schizophrenia and schizoaffective disorder; study completed with re…
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of PF-02545920 in psychiatrically stable subjects with schizophrenia; co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole [Phase 2]
Phase 2 open-label study evaluating usability of the MIND1 medical information device in adults with schizophrenia treated with aripiprazole…
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: A Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in Ethiopia [Phase 4]
Phase 4 clinical trial evaluating folate with B12 in patients with residual schizophrenia symptoms conducted in Ethiopia has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the combination of dronabinol and clonidine for cannabis dependence in patients with schizophrenia was t…
-
CLINICAL_TRIALS research · 2018-08-01Clinical Trial Update: Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels [NA]
This clinical trial investigates whether noninvasive brain stimulation alters brain-derived neurotrophic factor (BDNF) levels in individuals…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness [Phase 4]
Phase 4 trial evaluating metformin in individuals with type 2 diabetes or prediabetes and schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Mobile Enhancement of Motivation in Schizophrenia [NA]
This clinical trial update indicates the Mobile Enhancement of Motivation in Schizophrenia study has completed.
-
FDA approval · 2018-07-27FDA Approved: PERSERIS — Original Application (Indivior Inc.)
The FDA approved Perseris (risperidone subcutaneous long-acting injectable) under its original NDA for adults with schizophrenia, introducin…
-
FDA approval · 2018-07-27FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved Janssen's supplemental application for RISPERDAL M-TAB (risperidone), resulting in updated labeling or expanded indications for…
-
CLINICAL_TRIALS research · 2018-07-24Clinical Trial Update: Recruitment of Patients Through Invitation Letters [NA]
This clinical trial update notes recruitment of participants with schizophrenia through invitation letters, and the study is reported as com…
-
CLINICAL_TRIALS research · 2018-07-19Clinical Trial Update: Study of Vitamin D in the Severely Mentally Ill [Phase 4]
A Phase 4 clinical trial from the Bronx Psychiatric Center evaluating Vitamin D (cholecalciferol) in adults with schizophrenia or schizoaffe…
-
CLINICAL_TRIALS withdrawal · 2018-07-18Clinical Trial Update: Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine [NA]
A clinical trial investigating whether green tea can prevent olanzapine-associated weight gain and dyslipidemia in patients with bipolar dis…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Treatment of Mania Symptoms With Drug Therapy [Phase 3]
A Phase 3 trial update announcing completion and posting of results for a drug therapy aimed at treating mania symptoms in bipolar Disorder …
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Clinical Trial of Tolcapone for Cognition in Schizophrenia [Phase 2]
Phase 2 clinical trial of tolcapone for cognition in schizophrenia was terminated; results posted in 2018.
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: Schizophrenia for "Life" - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia
A completed registry and interview study focusing on elderly individuals with lifelong schizophrenia.
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy [Phase 4]
A Phase 4 trial comparing oral antipsychotics with injectable antipsychotics for relapse prevention in schizophrenia and schizoaffective dis…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions [Phase 4]
Phase 4 trial investigating D-Cycloserine augmentation of CBT for delusions in schizophrenia-spectrum conditions has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia [Phase 3]
Phase 3 trial evaluating cariprazine for prevention of relapse in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia [NA]
The clinical trial investigating the use of electronic cigarettes to promote smoking reduction among individuals with schizophrenia has comp…
-
CLINICAL_TRIALS research · 2018-07-05Clinical Trial Update: Imaging Cannabinoid CB1 Receptors in Schizophrenia
The NIMH-sponsored study imaging cannabinoid CB1 receptors in schizophrenia has been terminated.
-
FDA approval · 2018-07-03FDA Approved: HALOPERIDOL DECANOATE — Original Application (Somerset Therapeutics, LLC)
FDA approved haloperidol decanoate, a long-acting injectable antipsychotic, under an original application filed by Somerset Therapeutics, LL…